NRSN compared with CVM: revenue, margins and what each company keeps, and the suppliers and customers both name

NRSNNeuroSense Therapeutics Ltd.

Mkt capRevenueRevenue

CVMCEL SCI Corp

Mkt capRevenueRevenue

Compare

NRSNNeuroSense Therapeutics Ltd.

CVMCEL SCI Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NRSN: latest quarter not drawable. CVM: latest quarter not drawable.Method ›

Price

rebased to 0%

NRSN, solidCVM, dashed

NRSNNeuroSense Therapeutics Ltd.

2.01▼−5.63%· post 2.01

Mkt cap$2.5M

CVMCEL SCI Corp

1.39▼−7.38%· post 1.40

ClosedOct 30 '26

Mkt cap$24.3M

Compare

ClosedOct 30 '26

NRSNNeuroSense Therapeutics Ltd.

CVMCEL SCI Corp

2.01▼−5.63%post 2.01

Price

1.39▼−7.38%post 1.40

$2.5M

Mkt cap

$24.3M

NRSN2.01▼−5.63%vsCVM1.39▼−7.38%ClosedOct 30 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NRSN 0

None

Shared 0

No disclosed counterparties: NRSN.

Only CVM 3

TEVATeva Pharmaceutical Industriescustomer

—Byron BioPharmaunlistedcustomer

—Orient Europharmaunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR